Arvinas (ARVN) Non-Current Debt (2017 - 2026)
Arvinas' (ARVN) quarterly Non-Current Debt came in at $500000.0 in Q1 2026, down 28.57% year-on-year from $700000.0 in Q1 2025, and up 25.0% quarter-over-quarter from $400000.0 in Q4 2025.
Arvinas (ARVN) Non-Current Debt (2017 - 2026) Analysis & Trends
Arvinas' Non-Current Debt history runs 10 years deep, the most recent figure standing at $500000.0 for Q1 2026.
- On a quarterly basis, Non-Current Debt fell 28.57% year-over-year to $500000.0 in Q1 2026; TTM through Mar 2026 was $500000.0, a 28.57% decrease from a year earlier, with the FY2025 full-year figure at $400000.0, down 50.0% from the prior year.
- Non-Current Debt grew to $500000.0 in Q1 2026 per ARVN's latest filing, from $400000.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $1.0 million in Q1 2022 and bottomed at $400000.0 in Q4 2025.
- The 5-year median for Non-Current Debt is $800000.0 (2023), against an average of $788235.3.
- Biggest YoY gain for Non-Current Debt was 0.0% in 2022; the steepest drop was 50.0% in 2022.
- Year by year, Non-Current Debt stood at $1.0 million in 2022, then dropped by 20.0% to $800000.0 in 2023, then changed by 0.0% to $800000.0 in 2024, then sank by 50.0% to $400000.0 in 2025, then grew by 25.0% to $500000.0 in 2026.
- Per Business Quant, the three latest ARVN Non-Current Debt figures stand at $500000.0 (Q1 2026), $400000.0 (Q4 2025), and $600000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 1.00 Mn |